Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer
Background. Circulating plasma mRNAs can be analyzed to identify putative cancer biomarkers. This study was conducted in an effort to detect plasma mRNA biomarkers capable of predicting pancreatic cancer (PACA) patient prognosis. Material and Methods. First, prognostic mRNAs that were differentially...
Main Authors: | Yan Du, Kai Yao, Qingbo Feng, Feiyu Mao, Zechang Xin, Peng Xu, Jie Yao |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Journal of Oncology |
Online Access: | http://dx.doi.org/10.1155/2021/6656337 |
Similar Items
-
pEVL: A Linear Plasmid for Generating mRNA IVT Templates With Extended Encoded Poly(A) Sequences
by: Alexandra E Grier, et al.
Published: (2016-01-01) -
Short-term efficacy of EVL, EIS, and TAI in treatment of esophageal variceal bleeding
by: ZHOU Nianlan
Published: (2014-07-01) -
Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer
by: Andrii Khomiak, et al.
Published: (2020-11-01) -
Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection
by: Natalia Gablo, et al.
Published: (2020-07-01) -
EVL is a novel focal adhesion protein involved in the regulation of cytoskeletal dynamics and vascular permeability
by: Joseph B. Mascarenhas, et al.
Published: (2021-10-01)